Auna S.A. (AUNA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
GOLD, NIC, SPFI, AUNA and FOX have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2026.
Auna S.A. (AUNA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Auna S.A. ( AUNA ) Q3 2025 Earnings Call November 21, 2025 8:00 AM EST Company Participants Ana Maria Mora Jesús Zamora Leon - President, CEO & Executive Chairman of the Board Gisele Ferrero - CFO & Executive VP Conference Call Participants Mauricio Cepeda - Morgan Stanley, Research Division Presentation Operator Good morning, and welcome to Auna's Third Quarter 2025 Earnings Conference Call. My name is Eric and I'll be the operator for today's call.
Auna S.A. (NYSE:AUNA ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Ana Maria Mora - Head of Investor Relations Gisele Remy Ferrero - CFO & Executive VP Jesús Antonio Zamora Leon - President, CEO & Executive Chairman of the Board Conference Call Participants Artur do Amaral Alves - Morgan Stanley, Research Division Leandro Bastos - Citigroup Inc., Research Division Operator Good morning, and welcome to Auna's Second Quarter 2025 Earnings Conference Call. My name is Ellie, and I will be your operator for today's call.
Auna S.A. (AUNA) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.03 per share a year ago.
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AUNA's integrated LatAm healthcare platform is undervalued due to short-term execution, not structural flaws. The payor-provider model drives superior margins, cost efficiencies, and creates a powerful ecosystem with strong operating leverage, especially in underutilized Mexican assets. Management is actively addressing physician onboarding and payor mix, with insurance-led strategies poised to drive patient volume and profitability recovery.
Auna S.A. (AUNA) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.10 per share a year ago.
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Auna S.A. (AUNA) and Coya Therapeutics, Inc. (COYA) have performed compared to their sector so far this year.
Here is how Auna S.A. (AUNA) and BioMarin Pharmaceutical (BMRN) have performed compared to their sector so far this year.